Latest Breaking News On - Malik slassi - Page 3 : comparemela.com

Mindset Pharma Inc.: Mindset Further Expands Portfolio of Psychedelic Drug Candidates with Third U.S. Provisional Patent Application; 50 Total New Psychedelic Patent-Pending Compounds Synthesized Mindset Pharma Inc. (CSE: MSET) ( Mindset or the Company ), a drug discovery and development company focused on developing next generation psychedelic medicines and related technologies for the treatment of neuropsychiatric and neurological indications with unmet needs, is pleased to announce that it has filed another provisional patent application with the United States Patent and Trademark Office. Mindset has synthesized several novel tryptamine compounds under its latest patent application, increasing the number of new patent-pending potential drug candidates synthesized under its new drug discovery and development program to an aggregate of 50 drug candidates.

United statesKostenloser wertpapierhandelMalik slassiJason atkinsonJames lanthierTrademark officeNewsfile corpMindset pharma incCorporate developmentCompany management discussionUnited states patentChief medicinal chemistஒன்றுபட்டது மாநிலங்களில்ஜேசன் அட்கின்சன்முத்திரை அலுவலகம்மனநிலை பார்மா இன்க்